We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$30.7B
AUM Growth
-$1.16B
Cap. Flow
-$167M
Cap. Flow %
-0.54%
Top 10 Hldgs %
37.44%
Holding
630
New
71
Increased
203
Reduced
261
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 29.53%
2 Healthcare 23.35%
3 Financials 11.26%
4 Communication Services 10.36%
5 Consumer Discretionary 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
26
Cigna
CI
$78.4B
$408M 1.33%
1,478,767
+55,839
+4% +$17.8M
KLAC icon
27
KLA
KLAC
$222B
$345M 1.12%
5,473,590
-35,610
-0.6% -$2.41M
DGX icon
28
Quest Diagnostics
DGX
$26B
$342M 1.11%
2,268,990
+26,214
+1% +$4.08M
LLY icon
29
Eli Lilly
LLY
$1.08T
$336M 1.09%
435,232
+6,368
+1% +$5.27M
PR
30
Permian Resources
PR
$17.4B
$153M 0.5%
10,630,626
DAR icon
31
Darling Ingredients
DAR
$9.32B
$144M 0.47%
4,273,193
-900,776
-17% -$34.1M
GSK icon
32
GSK
GSK
$107B
$140M 0.46%
4,153,616
+446,568
+12% +$16.1M
IVV icon
33
iShares Core S&P 500 ETF
IVV
$858B
$128M 0.42%
+218,200
New +$129M
VOD icon
34
Vodafone
VOD
$37.1B
$124M 0.4%
14,598,375
+2,238,935
+18% +$20.4M
SQM icon
35
Sociedad Química y Minera de Chile
SQM
$19.3B
$120M 0.39%
3,302,897
+177,323
+6% +$6.94M
MFC icon
36
Manulife Financial
MFC
$73B
$118M 0.38%
3,850,803
-467,553
-11% -$14.5M
KOS icon
37
Kosmos Energy
KOS
$1.47B
$112M 0.36%
32,627,567
+5,906,210
+22% +$22.5M
RUN icon
38
Sunrun
RUN
$2.26B
$98.3M 0.32%
10,622,430
-496,231
-4% -$6.16M
AMRC icon
39
Ameresco
AMRC
$980M
$94.7M 0.31%
4,031,124
-178,447
-4% -$5.15M
DB icon
40
Deutsche Bank
DB
$67.9B
$93.1M 0.3%
5,400,467
+2,266,996
+72% +$39M
YPF icon
41
YPF
YPF
$19.7B
$78.4M 0.25%
1,843,178
-763,764
-29% -$25.1M
GE icon
42
GE Aerospace
GE
$364B
$76.3M 0.25%
457,321
+21,368
+5% +$3.81M
IBM icon
43
IBM
IBM
$213B
$72.7M 0.24%
330,772
-54,261
-14% -$12.1M
PFE icon
44
Pfizer
PFE
$143B
$71M 0.23%
2,676,738
+464,885
+21% +$12.6M
VZ icon
45
Verizon
VZ
$197B
$68.3M 0.22%
1,708,848
-2,741
-0.2% -$116K
ARRY icon
46
Array Technologies
ARRY
$740M
$67.4M 0.22%
11,158,312
+3,020,200
+37% +$19.3M
SEDG icon
47
SolarEdge
SEDG
$2.37B
$67.4M 0.22%
4,953,698
+641,915
+15% +$9.88M
BAC icon
48
Bank of America
BAC
$429B
$67.3M 0.22%
1,532,028
-515,194
-25% -$22.7M
VIST icon
49
Vista Energy
VIST
$7.35B
$66.8M 0.22%
1,234,108
+72,500
+6% +$3.74M
C icon
50
Citigroup
C
$213B
$63.9M 0.21%
907,166
-154,001
-15% -$10.4M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2024 Portfolio in Review

As of Q4 2024, Grantham, Mayo, Van Otterloo & Co (GMO) held 630 positions worth $30.7B, down 3.6% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2024 filing shows 71 new, 203 increased, 261 reduced and 60 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 218,200 shares worth $128M. The largest sale was TJX Companies, an estimated $229M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2024 buy was iShares Core S&P 500 ETF: 218,200 shares worth $128M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Thermo Fisher Scientific in Q4 2024, an estimated $352M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2024 reduction was TJX Companies, cutting an estimated $229M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $38.4M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 37% of its $30.7B portfolio in Q4 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 71 new positions and closed 60 in Q4 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 3.6% quarter-over-quarter to $30.7B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2024, filed 13 Feb 2025.